Dupilumab monoclonal antibody drug. Targets alpha subunit of interleukin-4 receptor and is indicated for the treatment of atopic #186824351
Description
Dupilumab monoclonal antibody drug. Targets alpha subunit of interleukin-4 receptor and is indicated for the treatment of atopic eczema. Generic name and stylized antibody representation